HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Ilaria Maccora Selected Research
Ilaria Maccora Research Topics
Disease
7
Uveitis
10/2023 - 01/2020
5
Juvenile Arthritis (Juvenile Idiopathic Arthritis)
07/2023 - 12/2021
4
Rheumatic Diseases (Rheumatism)
01/2023 - 06/2020
3
Infections
11/2023 - 12/2021
3
Inflammation (Inflammations)
01/2023 - 01/2020
2
Obesity
03/2023 - 01/2019
2
COVID-19 related pediatric multisystem inflammatory disease
03/2023 - 01/2022
1
Lymphadenopathy
04/2024
1
Arthritis (Polyarthritis)
03/2024
1
Central Nervous System Vasculitis
12/2023
1
Polymyositis
10/2023
1
Pulmonary Embolism
03/2023
1
Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome)
03/2023
1
Leishmaniasis
03/2023
1
Visceral Leishmaniasis (Kala Azar)
03/2023
1
Acquired Hyperostosis Syndrome (SAPHO Syndrome)
01/2023
1
Calcinosis
01/2023
1
Dermatomyositis (Dermatopolymyositis)
01/2023
1
Osteomyelitis
01/2023
1
Spondylarthropathies
01/2023
1
Agammaglobulinemia (Hypogammaglobulinemia)
09/2022
1
Communicable Diseases (Infectious Diseases)
09/2022
1
Heart Arrest (Cardiac Arrest)
08/2022
1
Myositis (Idiopathic Inflammatory Myopathies)
02/2022
1
Pain (Aches)
01/2022
1
Disease Progression
12/2021
1
Tuberculosis (Tuberculoses)
12/2021
1
Retinitis
11/2021
1
Papilledema
11/2021
1
Optic Neuritis (Retrobulbar Neuritis)
11/2021
1
Conjunctivitis
11/2021
1
Retinal Vasculitis
11/2021
1
Arteritis
01/2021
1
Aneurysm (Aneurysms)
01/2021
1
Fever (Fevers)
01/2021
1
Mucocutaneous Lymph Node Syndrome (Kawasaki Disease)
01/2021
1
Sarcoidosis (Schaumann Disease)
03/2020
1
Acquired Immunodeficiency Syndrome (AIDS)
01/2020
1
Rheumatoid Arthritis
01/2019
1
Overweight
01/2019
Drug/Important Bio-Agent (IBA)
5
Adalimumab (Humira)
FDA Link
02/2022 - 01/2020
3
Biomarkers (Surrogate Marker)
IBA
03/2023 - 01/2020
3
Cytokines
IBA
01/2023 - 01/2019
3
tocilizumab (atlizumab)
FDA Link
02/2022 - 01/2020
2
secukinumab
IBA
03/2024 - 01/2023
2
Mycophenolic Acid (Cellcept)
FDA Link
Generic
12/2023 - 09/2022
2
Janus Kinase Inhibitors
IBA
07/2023 - 01/2023
2
baricitinib
IBA
01/2023 - 01/2023
2
Intravenous Immunoglobulins (IVIG)
FDA Link
01/2022 - 01/2021
2
Adrenal Cortex Hormones (Corticosteroids)
IBA
01/2022 - 03/2020
2
Methotrexate (Mexate)
FDA Link
Generic
01/2022 - 01/2020
2
Antirheumatic Agents (DMARD)
IBA
12/2021 - 01/2021
2
Steroids
IBA
01/2021 - 01/2021
2
Interleukin-1 (Interleukin 1)
IBA
01/2021 - 01/2020
1
Interleukin-18 (Interleukin 18)
IBA
04/2024
1
Tumor Necrosis Factor Inhibitors
IBA
03/2024
1
COVID-19 Vaccines
IBA
11/2023
1
Ligases (Synthetase)
IBA
10/2023
1
Heparin (Liquaemin)
FDA Link
Generic
03/2023
1
TES
IBA
03/2023
1
fibrin fragment D (D-dimer)
IBA
03/2023
1
Interleukin-17 (Interleukin 17)
IBA
01/2023
1
Biosimilar Pharmaceuticals
IBA
11/2022
1
Immunoglobulin G (IgG)
IBA
09/2022
1
Immunoglobulins (Immunoglobulin)
IBA
09/2022
1
Infliximab (Remicade)
FDA Link
02/2022
1
Etanercept (Enbrel)
FDA Link
02/2022
1
Rituximab (Mabthera)
FDA Link
02/2022
1
Abatacept (Orencia)
FDA Link
01/2022
1
Hyaluronic Acid (Hyaluronan)
IBA
01/2022
1
Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
IBA
01/2022
1
Interleukin 1 Receptor Antagonist Protein (Anakinra)
FDA Link
01/2022
1
Peptides (Polypeptides)
IBA
12/2021
1
Antibodies
IBA
12/2021
1
1-(2-chloroethyl)-1-nitrosourea (CNU)
IBA
12/2021
1
veltuzumab
IBA
11/2021
1
Genetic Markers (Genetic Marker)
IBA
01/2020
1
C-Reactive Protein
IBA
01/2019
Therapy/Procedure
5
Therapeutics
12/2023 - 01/2020
2
Biological Therapy
02/2022 - 01/2020
1
Slit Lamp
10/2023
1
Lasers (Laser)
10/2023
1
Central Venous Catheters
03/2023
1
Artificial Respiration (Mechanical Ventilation)
03/2023
1
Extracorporeal Membrane Oxygenation
03/2023
1
Cardiopulmonary Resuscitation (CPR)
08/2022
1
Resuscitation
08/2022
1
Precision Medicine
02/2022
1
Injections
01/2022
1
Drug Therapy (Chemotherapy)
12/2021